Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sense Proteomic

1998 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Developer of proprietary technology to discover and commercialise auto antibody biomarkers. The company offers biomaker panels for use with cancer and autoimmune disease patients.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Drug Delivery
Primary Office
  • Unit 4
  • The Switchback Gardner Road
  • Maidenhead Berkshire SL6 7RJ
  • England

+44 01628 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sense Proteomic’s full profile, request a free trial.

Sense Proteomic Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 17-Mar-2009 Completed Generating Revenue
4. Spin-Off 04-Jun-2008 Completed Generating Revenue
3. Merger/Acquisition 16-Jan-2003 Completed Startup
2. Early Stage VC 28-Jan-2002 Completed Startup
1. Spin-Off 19-Nov-1998 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Sense Proteomic Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Apax Partners PE/Buyout Majority 000 0000 000000 0
Oxford Spin-out Equity Management Venture Capital Minority 000 0000 000000 0
Oxford University Innovation Venture Capital Minority 000 0000 000000 0
Procognia Corporation Majority 000 0000 000000 0
University of Cambridge Endowment University 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Sense Proteomic Executive Team (4)

Name Title Board
Seat
Contact
Info
Rachel Fallon Director

3 Former Executives

You’re viewing 1 of 4 executives. Get the full list »